Shares of Cavium Inc. (NASDAQ:CAVM) were up 6.4% during trading on Wednesday . The company traded as high as $39.48 and last traded at $38.95, with a volume of 1,435,590 shares changing hands. The stock had previously closed at $36.61.

A number of analysts have commented on CAVM shares. Brean Capital started coverage on shares of Cavium in a research report on Tuesday, May 3rd. They set a “buy” rating and a $67.00 price target on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $66.00 price target (down previously from $75.00) on shares of Cavium in a research report on Thursday, April 28th. Roth Capital reaffirmed a “buy” rating on shares of Cavium in a research report on Thursday, April 28th. Jefferies Group reaffirmed a “buy” rating on shares of Cavium in a research report on Thursday, April 28th. Finally, Canaccord Genuity reaffirmed a “buy” rating on shares of Cavium in a research report on Monday, April 18th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the stock. Cavium currently has an average rating of “Hold” and a consensus target price of $61.87.

The firm’s 50-day moving average price is $44.50 and its 200-day moving average price is $53.97. The company’s market capitalization is $2.25 billion.

Cavium (NASDAQ:CAVM) last announced its earnings results on Wednesday, April 27th. The semiconductor provider reported $0.25 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.25. During the same period in the previous year, the firm posted $0.40 EPS. The company had revenue of $101.90 million for the quarter, compared to the consensus estimate of $102.13 million. The company’s revenue for the quarter was up .1% on a year-over-year basis. On average, analysts anticipate that Cavium Inc. will post $1.33 earnings per share for the current fiscal year.

A number of large investors have bought and sold shares of the company. OppenheimerFunds Inc. raised its stake in Cavium by 21.0% in the fourth quarter. OppenheimerFunds Inc. now owns 1,579,032 shares of the semiconductor provider’s stock valued at $103,758,000 after buying an additional 274,402 shares during the last quarter. Nationwide Fund Advisors raised its stake in Cavium by 31.8% in the fourth quarter. Nationwide Fund Advisors now owns 223,256 shares of the semiconductor provider’s stock valued at $14,670,000 after buying an additional 53,894 shares during the last quarter. Thornburg Investment Management Inc. acquired a new stake in Cavium during the fourth quarter valued at approximately $10,703,000. Old Mutual Global Investors UK Ltd. acquired a new stake in Cavium during the fourth quarter valued at approximately $4,083,000. Finally, Brown Advisory Inc. raised its stake in Cavium by 4.4% in the fourth quarter. Brown Advisory Inc. now owns 320,714 shares of the semiconductor provider’s stock valued at $21,074,000 after buying an additional 13,440 shares during the last quarter.

Cavium, Inc is a provider of semiconductor processors, which enables processing for wired and wireless networking, communications, storage, cloud, wireless, security, video and connected home and office applications. The Company’s products include OCTEON, OCTEON Fusion, OCTEON XL, LiquidIO, NITROX, NEURON Search, ThunderX, Xpliant and XPA.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.